Internship

2025 Summer Internship Product Development

Posted on 10/8/2024

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

No H1B Sponsorship

Summit, NJ, USA + 2 more

More locations: Franklin Township, NJ, USA | Devens, MA, USA

Onsite interns residing more than 50 miles away may be eligible for a travel/housing stipend.

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Required Skills
Business Analytics
Requirements
  • Candidates must be currently enrolled in an accredited university program seeking an undergraduate or dual-degree (e.g., B.A., B.S., B.A./M.A., B.S./M.S.) in biochemistry, biology, biomedical engineering, business analytics, chemical engineering, chemistry, industrial engineering, pharmacy or supply chain.
  • Seniors graduating in Spring or Summer 2025 are eligible to apply only if they will be continuing their education for the following semester (Fall 2025).
  • Must include GPA on resume for consideration (program requires GPA of 3.0 or greater).
  • Must have good oral/written communication skills and be able to work in a team environment.
  • All candidates must be authorized to work in the US at the time of hire. Please note that immigration or visa sponsorship is not available for this position.
Responsibilities
  • Summer interns will work with mentors for ~10 weeks on a guided research project within a PD Project Team.
  • The program is organized to ensure that interns gain valuable industry and functional experience, work on challenging assignments, learn about BMS and meet diverse company representatives.

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's licensing agreement with Prime Medicine boosts its cell and gene therapy pipeline.
  • The focus on personalized medicine enhances BMS's position in precision oncology.
  • BMS's commitment to ESG initiatives aligns with industry sustainability trends.

What critics are saying

  • BMS faces potential financial liabilities from the refiled $6.4 billion UMB lawsuit.
  • The lawsuit against HRSA and HHS could lead to regulatory challenges.
  • High R&D costs and risks are associated with the AI Proteins collaboration.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb focuses on innovative medicines in oncology, immunology, and cardiovascular areas.
  • The company invests heavily in R&D to develop new drugs and therapies.
  • BMS offers both innovative and generic medicines, increasing healthcare accessibility.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE